Literature DB >> 17079582

Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy.

Namasivayam Ambalavanan1, Waldemar A Carlo, Seetha Shankaran, Carla M Bann, Steven L Emrich, Rosemary D Higgins, Jon E Tyson, T Michael O'Shea, Abbot R Laptook, Richard A Ehrenkranz, Edward F Donovan, Michele C Walsh, Ronald N Goldberg, Abhik Das.   

Abstract

OBJECTIVE: The goals were to identify predictor variables and to develop scoring systems and classification trees to predict death/disability or death in infants with hypoxic-ischemic encephalopathy.
METHODS: Secondary analysis of data from the multicenter, randomized, controlled, National Institute of Child Health and Human Development Neonatal Research Network trial of hypothermia in hypoxic-ischemic encephalopathy was performed. Data for 205 neonates diagnosed as having hypoxic-ischemic encephalopathy were studied. Logistic regression analysis was performed by using clinical and laboratory variables available within 6 hours of birth, with death or moderate/severe disability at 18 to 22 months or death as the outcomes. By using the identified variables and odds ratios, scoring systems to predict death/disability or death were developed, weighting each predictor in proportion to its odds ratio. In addition, classification and regression tree analysis was performed, with recursive partitioning and automatic selection of optimal cutoff points for variables. Correct classification rates for the scoring systems, classification and regression tree models, and early neurologic examination were compared.
RESULTS: Correct classification rates were 78% for death/disability and 71% for death with the scoring systems, 80% and 77%, respectively, with the classification and regression tree models, and 67% and 73% with severe encephalopathy in early neurologic examination. Correct classification rates were similar in the hypothermia and control groups.
CONCLUSIONS: Among neonates diagnosed as having hypoxic-ischemic encephalopathy, the classification and regression tree model, but not the scoring system, was superior to early neurologic examination in predicting death/disability. The 3 models were comparable in predicting death. Only a few components of the early neurologic examination were associated with poor outcomes. These scoring systems and classification trees, if validated, may help in assessments of prognosis and may prove useful for risk-stratification of infants with hypoxic-ischemic encephalopathy for clinical trials.

Entities:  

Mesh:

Year:  2006        PMID: 17079582     DOI: 10.1542/peds.2006-1591

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children's Hospitals Neonatal Consortium HIE focus group.

Authors:  A N Massaro; K Murthy; I Zaniletti; N Cook; R DiGeronimo; M Dizon; S E G Hamrick; V J McKay; G Natarajan; R Rao; D Smith; R Telesco; R Wadhawan; J M Asselin; D J Durand; J R Evans; F Dykes; K M Reber; M A Padula; E K Pallotto; B L Short; A M Mathur
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

2.  Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.

Authors:  C Michael Cotten; Amy P Murtha; Ronald N Goldberg; Chad A Grotegut; P Brian Smith; Ricki F Goldstein; Kimberley A Fisher; Kathryn E Gustafson; Barbara Waters-Pick; Geeta K Swamy; Benjamin Rattray; Siddhartha Tan; Joanne Kurtzberg
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

3.  Perinatal risk factors for severe injury in neonates treated with whole-body hypothermia for encephalopathy.

Authors:  Christopher P Wayock; Rachel L Meserole; Suchi Saria; Jacky M Jennings; Thierry A G M Huisman; Frances J Northington; Ernest M Graham
Journal:  Am J Obstet Gynecol       Date:  2014-03-18       Impact factor: 8.661

4.  Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy.

Authors:  Seetha Shankaran; Abbot R Laptook; Jon E Tyson; Richard A Ehrenkranz; Carla M Bann; Abhik Das; Rosemary D Higgins; Rebecca Bara; Athina Pappas; Scott A McDonald; Ronald N Goldberg; Michele C Walsh
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

5.  Predictive value of an early amplitude integrated electroencephalogram and neurologic examination.

Authors:  Seetha Shankaran; Athina Pappas; Scott A McDonald; Abbot R Laptook; Rebecca Bara; Richard A Ehrenkranz; Jon E Tyson; Ronald Goldberg; Edward F Donovan; Avroy A Fanaroff; Abhik Das; W Kenneth Poole; Michele Walsh; Rosemary D Higgins; Cherie Welsh; Walid Salhab; Waldemar A Carlo; Brenda Poindexter; Barbara J Stoll; Ronnie Guillet; Neil N Finer; David K Stevenson; Charles R Bauer
Journal:  Pediatrics       Date:  2011-06-13       Impact factor: 7.124

6.  Short-term outcomes of newborns with perinatal acidemia who are not eligible for systemic hypothermia therapy.

Authors:  Tara L DuPont; Lina F Chalak; Michael C Morriss; P Jeannette Burchfield; Lucy Christie; Pablo J Sánchez
Journal:  J Pediatr       Date:  2012-08-04       Impact factor: 4.406

Review 7.  Neonatal encephalopathy: treatment with hypothermia.

Authors:  Seetha Shankaran
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 8.  Hypothermia for neonatal hypoxic-ischemic encephalopathy: NICHD Neonatal Research Network contribution to the field.

Authors:  Seetha Shankaran; Girija Natarajan; Lina Chalak; Athina Pappas; Scott A McDonald; Abbot R Laptook
Journal:  Semin Perinatol       Date:  2016-06-23       Impact factor: 3.300

9.  Therapeutic hypothermia for neonatal encephalopathy.

Authors:  Seetha Shankaran
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

10.  Association between urinary lactate to creatinine ratio and neurodevelopmental outcome in term infants with hypoxic-ischemic encephalopathy.

Authors:  William Oh; Rebecca Perritt; Seetha Shankaran; Matthew Merritts; Edward F Donovan; Richard A Ehrenkranz; T Michael O'Shea; Jon E Tyson; Abbot R Laptook; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2008-05-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.